We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Galapagos Subsidiary BioFocus Collaborate with Senexis

News   Dec 02, 2005

 
Galapagos Subsidiary BioFocus Collaborate with Senexis
 
 
 

RELATED ARTICLES

Increasing the Odds of Synthetic Chemistry Success

News

Chemists show how analyzing previously published chemical reaction data can predict how hypothetical reactions may proceed, narrowing the range of conditions chemists need to explore. Their algorithmic prediction process, which includes aspects of machine learning, can save valuable time and resources in chemical research.

READ MORE

Early Benefit Assessment Exposes Weaknesses in the Development of New Drugs

News

More than half of the drugs that have entered the market in Germany since then have emerged from these assessments without any proven added benefit. In a new publication using the first 216 assessments, researchers examine the reasons for this sobering result and develop suggestions for improvements in drug development.

READ MORE

Clinical Trial for New Anti-obesity Drug Set to Launch

News

The Alberta Diabetes Institute will be at the centre of a new clinical trial for an anti-obesity drug targeting people with rare genetic conditions that contribute to their obesity.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE